Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region
Open Access
- 1 January 2022
- journal article
- review article
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 15, 1-12
Abstract
Chronic rhinosinusitis (CRS) is defined as the inflammation of nose and paranasal sinuses, affecting the patients’ quality of life and productivity. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a principal clinical entity confirmed by the existence of chronic sinonasal inflammation and is characterized by anterior or posterior rhinorrhea, nasal congestion, hyposmia and/or facial pressure or facial pain. Several epidemiologic studies have revealed wide variations in the incidence of CRS among regions globally ranging from 4.6% to 12%. The Gulf countries are also witnessing an unprecedented burden of CRSwNP. According to the current clinical guidelines, glucocorticosteroids and antibiotics are the principal pharmacotherapeutic approaches. Endoscopic sinus surgery is recommended for those who have failed maximal pharmacotherapy. Recently, biologics are considered as an alternative best approach due to the complications associated with medical therapy and surgery. However, precise data on the clinical position of biologic agents in the management of CRSwNP in the Gulf region is not available. The present review article addresses the current diagnostic and management approaches for CRSwNP and also emphasizes the role of emerging biologics in the current treatment strategies for CRSwNP in the Gulf region. Further, a consensus protocol was convened to rationalize the guideline recommendations, strategize the best practices with biologics, and develop clinical practice guidelines for all primary-care specialists in the Gulf region. The consensus-based report will be a useful reference tool for primary-care physicians in primary-healthcare settings, regarding the appropriate time for the initiation of biological treatment in the Gulf region.Keywords
This publication has 31 references indexed in Scilit:
- A survey on chronic rhinosinusitis: opinions from experts of 50 countriesEuropean Archives of Oto-Rhino-Laryngology, 2016
- Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposisJournal of Allergy and Clinical Immunology, 2015
- Targeting key proximal drivers of type 2 inflammation in diseaseNature Reviews Drug Discovery, 2015
- Aspirin hypersensitivity in Iranian patients with chronic rhinosinusitis and nasal polyposis: prevalence and comorbid factorsClinical and Translational Allergy, 2014
- University of Pennsylvania Smell Identification on Iranian PopulationIranian Red Crescent Medical Journal, 2014
- Role of frontal sinus surgery in nasal polyp recurrenceThe Laryngoscope, 2012
- Prevalence of sinonasal outcome test (SNOT‐22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective auditClinical Otolaryngology, 2012
- An update on the classifications, diagnosis, and treatment of rhinosinusitisCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2009
- Adult Chronic Rhinosinusitis: Definitions, Diagnosis, Epidemiology, and PathophysiologyOtolaryngology–Head and Neck Surgery, 2003
- Editors and Reviewers: Supporting Peer‐Review PublishingOtolaryngology–Head and Neck Surgery, 2003